本powerpoint演示文稿首先简要概述氯化铝的形成和命运 药物活性化合物 加拿大的废水消毒。研究目标包括以下几点:研究生物降解动力学 当与水中的氯反应时，选择PHAC 纯净水样本； 确定副产物的形成动力学；和 调查PhAC降解和副产物 在实际废水样本中形成。演示文稿摘要包括以下内容: 由于以下原因，可能会形成氯化副产品: 目前的消毒策略； 在实验室水中的实验显示了伪一级动力学 吉非罗齐、萘普生、双氯芬酸和布洛芬； 零级氯化吉非罗齐副产物 关于自身的动力学，通常适合模型 平行反应； 迄今为止的废水试验显示吉非罗齐降解， 但没有副产品的形成；和 迄今为止，没有关于氯化副产品的毒性数据。 包括表格、数字。

This powerpoint presentation begins by providing a brief overview of the formation and fate of chlorinated pharmaceutically active compounds during wastewater disinfection in Canada. Research objectives included the following: investigate the kinetics of degradation for selected PhACs when reacted with chlorine in pure water samples; determine kinetics of formation of byproducts; and, investigate PhAC degradation and byproduct formation in actual wastewater samples. Presentation summary includes the following: potential for chlorinated byproduct formation exists due to current disinfection strategies; experiments in lab water show pseudo-first order kinetics for Gemfibrozil, Naproxen, Diclofenac, and Ibuprofen; chlorinated gemfibrozil byproducts formed by zero order kinetics with respect to themselves, generally fit model for parallel reactions; wastewater trials to date show degradation of Gemfibrozil, but no formation of byproducts; and, to date, no toxicity data exists on chlorinated byproducts. Includes tables, figures.